Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in New York, New York · 44 W 74TH ST STE 3F, NEW YORK, NY 10023-2463 · (917) 553-2700
Part of Exelixis Clinical
As of July 2026, 3 paid clinical trials are recruiting at Exelixis Clinical in New York, New York. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (3)
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
for Solid Tumor
11 locations incl. San Francisco
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06952010·Phase 1·Recruiting·Listed Apr 2025
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for Advanced Solid Tumor
13 locations incl. Jacksonville
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05932862·Phase 1·Recruiting·Listed Jul 2023
More research sites in New York
- Memorial Sloan Kettering Cancer Center (460 trials)
- NYU Langone Health (304 trials)
- Icahn School of Medicine at Mount Sinai (257 trials)
- Columbia University Irving Medical Center (178 trials)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) (157 trials)
- Weill Cornell Medicine (134 trials)
- Mount Sinai Hospital (121 trials)
- Columbia University Medical Center (119 trials)
- Columbia University (105 trials)
- Hospital for Special Surgery (66 trials)
Explore more
Paid clinical trials in New York, NY · New York clinical trials